Dean VandeKamp
General Partner @ Cultivation Capital
St Louis, United States
Dean VandeKamp is a Series B investor at Cultivation Capital in St Louis focused on Life Science and Therapeutics. Dean VandeKamp - General Partner @ Cultivation Capital
- Total investments:
- 1
- Last investment:
- Lead investor:
- 100%
Last updated:
For AI agents: llms.txt
Industries Dean VandeKamp invests in
Stages Dean VandeKamp invests in
Countries Dean VandeKamp invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Life Science 1 (100%)
- Therapeutics 1 (100%)
- Biotechnology 1 (100%)
- Medical Device 1 (100%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Mobius Therapeutics is an early-stage venture focused on ophthalmic surgery solutions. Its first product, Mitosol, is a system for delivering antifibrotic agents in glaucoma, refractive, and corneal surgery. It is awaiting regulatory approval, with additional product applications in earlier stages of development. | $5M / Series B / Oct 10, 2013 |
About Cultivation Capital
Cultivation Capital is a venture capital firm that manages a family of funds focused on early-stage investing. Most of our initial investments are during a startup’s Seed or Series A phase, and our initial checks range from $500k – $3.5M. Our industries of focus include life sciences and health tech, software and IT, agriculture tech, andgeospatial tech.
Cultivation Capital Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Alana Mann
Principal
|
|||
Andy Dearing
General Partner
|
|||
Brian Matthews
Co-Founder & General Partner
|
|||
David Smoller
General Partner - Life Sciences Fund
|
|||
|
Dean VandeKamp
General Partner
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Dean VandeKamp invest in?
Dean VandeKamp invests primarily in Life Science, Therapeutics and Biotechnology startups, most often at Series B stage. Most of the 1 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Dean VandeKamp?
Public channels for Dean VandeKamp include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Dean VandeKamp last invest?
The most recent investment recorded for Dean VandeKamp closed in Oct 2013. Shizune tracks 1 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Sep 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
